Regulatory/Legislative News

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

Nearly 16 million Americans are living with vision impairment that is undiagnosed or untreated because eye and vision health lags in priority in the United States, according to a new report from the National Academies of Sciences, Engineering, and Medicine.

COPENHAGEN — At Euretina 2016, José Carlos Pastor, MD, talks about the case of cytotoxic batches of a perfluorocarbon liquid that led to blindness in 117 patients in Spain last year. The case casts doubts on the validity of regulations and international standards for the testing of medical devices.

Recent FDA activity includes the addition of an ocular indication for AbbVie’s Humira and the issuance of two complete response letters, one to Ocular Therapeutix and one to Valeant, citing manufacturing concerns. Ocular Surgery News compiled these stories from Healio.com/OSN.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

July’s hot topics in ophthalmology ranged from long-awaited FDA approvals including Shire’s lifitegrast ophthalmic solution for dry eye disease to Allergan’s de novo application submission to the FDA for the Oculeve intranasal tear neurostimulator.

The United States "will be better off" due to the progress that the Affordable Care Act has made in addressing inadequacies in the health care system, according to a special communication issued by President Barack Obama, JD.

OVIEDO, Spain — The U.K.’s decision to leave the European Union created shock and concern among the attendees of the European Meeting of Young Ophthalmologists.

PRAGUE — At the European Glaucoma Society Congress, Anton Hommer, MD, expresses the importance of prescribing glaucoma patients brand name glaucoma medications.